Patients and Methods: Patients with advanced SCCHN who were refractory to standard therapies and who had at least one assessable and accessible lesion were enrolled.
研究方法和对象：晚期的SCCHN患者，并且能耐受标准的化疗，而且至少有一次疗效评价和能耐受的肿瘤负荷。
Patients and Methods: Patients with advanced SCCHN who were refractory to standard therapies and who had at least one assessable and accessible lesion were enrolled.
研究方法和对象：晚期的SCCHN患者，并且能耐受标准的化疗，而且至少有一次疗效评价和能耐受的肿瘤负荷。
应用推荐